Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

Bianca Muñiz, a three-time cancer survivor first diagnosed at age 11, shared her powerful story on International Childhood ...

Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...

Kathy Bates has revealed why she decided against reconstruction surgery after her breast cancer diagnosis and mastectomy in ...

Company appoints Anil K. Sood, MD, as inaugural member Company continues to advance lead program, KAD101 for the treatment of ...

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...